Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

Pierre Fabre has unveiled new Phase 3 data on its encorafenib triplet therapy in the treatment of BRAF V600E-mutant metastatic colorectal cancer (...
The Department of Health and Social Care (DHSC) plans to spend £3 million on emergency transport for medicines in the case of a no-deal Brexit.
Pfizer and Sangamo Therapeutics have shared new Phase 1/2 data for their investigational SB-525 gene therapy in the treatment of haemophilia A,...
A new urine test can diagnose cases of aggressive prostate cancer more quickly than invasive biopsies.
President Donald Trump has said that the White House is working on a ‘favoured nation clause’ to ensure the United States pays the same price for...
The Association of the British Pharmaceutical Industry (ABPI) has announced that its Chief Executive Mike Thompson is to retire from his role by...
Check out this weeks' top ten stories on Pharmafile.com
NICE has announced its decision to recommend Pfizer’s Vizimpro (Dacomitinib) in the treatment of non-small-cell lung cancer (NSCLC) – a U-turn on...
The FDA has made the controversial decision to approve the nuclear export inhibitor Xpovio from Karyopharm Therapeutics, in combination with...
There have been price hikes on more than 3,400 drugs in the United States in the first six months of 2019, according to analysis by Rx Savings...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches